The significant associations between VEGF elevations, critical pathophysiological processes (microvascular dysfunction, ineffective angiogenesis, and fibrosis) and clinical manifestations suggest that VEGF might represent a useful diagnostic and prognostic biomarker in SSc. Here, VEGFA is linked to systemic sclerosis.